Skip to content

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01966484
Enrollment
100
Registered
2013-10-21
Start date
2013-10-31
Completion date
Unknown
Last updated
2014-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubating Conditions, Performance With Respiratory Exercise Device, Postoperative Myalgia

Keywords

Succinylcholine, Mivacurium, Rigid Bronchoscopy, Intubating conditions, Short Procedure

Brief summary

Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as rigid bronchoscopy. A alternative is the application of low dose mivacurium, reversed with neostigmine. The investigators compare the intubating conditions, incidence of postoperative myalgia (POM), patient satisfaction and the postoperative performance with respiration exercise device for these two muscle relaxants.

Interventions

DRUGSuccinylcholine

Anaesthesia was induced and maintained with propofol(1-2mg/kg and 5mg/kg/h) and remifentanil (1µg/kg and 0,2µ/kg/min). The study arm is immobilized and a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. the patients receive the muscle relaxant according to the study group.

Anaesthesia was induced and maintained with propofol(1-2mg/kg and 5mg/kg/h) and remifentanil (1µg/kg and 0,2µ/kg/min). The study arm is immobilized and a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. the patients receive the muscle relaxant according to the study group.

Sponsors

Dr. Horst Schmidt Klinik GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 18 yr * scheduled for elective rigid bronchoscopy

Exclusion criteria

* known neuromuscular disease * significant hepatic or renal dysfunction * family history of malignant hyperthermia * known allergy to one of the drugs used in this protocol * pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Intubating conditionAfter induction of general anaesthesia (after 3-5 minutes)For measuring the intubation conditions the scoring system proposed for Good clinical Research Practice using the following variables is used: conditions of inserting the rigid bronchoscope, vocal cord position and coughing

Secondary

MeasureTime frameDescription
Postoperative Myalgia72 hours after interventionThe severity of POM was measured using a four point scale: 0=no myalgia 1. minor pain limited to one area of the body 2. muscle pain or stiffness noticed spontaneously by the patient, which may have required analgesic therapy 3. generalized, severe or incapacitating discomfort
postintervention performance with a expiration exercise device72 hours after interventionThe performance with a respiration exercise device, which measures the expirational volume, before and after intervention.

Other

MeasureTime frameDescription
Patient satisfaction72 hours after interventionMeasurement on a numeric ten point scale (10=totally satisfied)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026